Changing oral contraceptives from prescription to over-the-counter status: An opinion statement of the women's health practice and research network of the american college of clinical pharmacy

Pharmacotherapy

Volumn 31, Issue 4, 2011, Pages 424-437

  McIntosh, Jennifer ^a   Rafie, Sally ^b   Wasik, Mitzi ^c   McBane, Sarah ^d   Lodise, Nicole M ^e   El Ibiary, Shareen Y ^f   Forinash, Alicia ^g   Kachlic, Marlowe Djuric ^c   Rowe, Emily ^h   Besinque, Kathy ⁱ  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^f MIDWESTERN UNIVERSITY   (United States)

^g ST LOUIS COLLEGE OF PHARMACY   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Collaborative drug therapy; Community pharmacy; Delivery of health care; Nonprescription drugs; Oral contraceptives; OTC; Over the counter status

Indexed keywords

ESTROGEN; GESTAGEN; NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT;

ATTITUDE TO HEALTH; BREAST CANCER; CLINICAL PHARMACY; COMMUNITY PROGRAM; CONSULTATION; DRUG CONTRAINDICATION; DRUG LEGISLATION; DRUG SAFETY; DRUG SCREENING; EMERGENCY CONTRACEPTION; GOVERNMENT REGULATION; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH EDUCATION; HORMONAL CONTRACEPTION; HUMAN; MEDICAID; MEDICAL RESEARCH; MEDICAL SOCIETY; NOTE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; PUBLIC HEALTH SERVICE; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; UNITED STATES; UNPLANNED PREGNANCY; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

CONSUMER PRODUCT SAFETY; CONTRACEPTIVES, ORAL; DRUG UTILIZATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; NONPRESCRIPTION DRUGS; PATIENT EDUCATION AS TOPIC; PRESCRIPTION DRUGS; SOCIETIES, PHARMACEUTICAL; WOMEN'S HEALTH SERVICES;

EID: 79953725127     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.4.424     Document Type: Note

References (68)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
2. Brown SS, Eisenberg L, Institute of Medicine (U.S.), Committee on Unintended Pregnancy. The best intentions: unintended pregnancy and the well-being of children and families. Washington, DC: National Academy Press, 1995.
3. Kost K, Landry DJ, Darroch JE. The effects of pregnancy planning status on birth outcomes and infant care. Fam Plann Perspect 1998;30:223-30.
4. Baydar N. Consequences for children of their birth planning status. Fam Plann Perspect 1995;27:228-234, 245.
5. Trussell J. The cost of unintended pregnancy in the United States. Contraception 2007;75:168-70. (Pubitemid 46217191)
6. Hoffman S. By the numbers: the public costs of teen childbearing. Washington, DC: National Campaign to Prevent Teen Pregnancy, 2006.
7. U.S. Department of Health and Human Services. Healthy people 2010, 2nd ed. With understanding and improving health and objectives for improving health. Washington, DC: U.S. Government Printing Office, 2000.
8. Institute of Medicine. Initial national priorities for comparative effectiveness research. Washington, DC: National Academies Press, 2009.
9. Tanouye E, Gutfeld R. Talks canceled on making 'pill' nonprescription. Wall Street Journal. January 28, 1993:b1.
10. Stein R. FDA approves plan B's over-the-counter sale: no prescription will be required for women 18 or older. Washington Post, August 25, 2006. Available from http://www.washingtonpost.com/wp-dyn/content/article/2006/08/24/ AR2006082400559.html. Accessed January 27, 2010.
11. Wild A, Corbett Cooren J. Emergency contraceptive is approved. Wall Street Journal, August 14, 2010. Available from http://online.wsj.com/article/ SB10001424052748703960004575428080054092078.html. Accessed January 27, 2010.
12. European Medicines Agency. CHMP assessment report for Ellaone. London, UK: European Medicines Agency, 2009.
13. Gardner JS, Miller L, Downing DF, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the direct access study. J Am Pharm Assoc (2003) 2008;48:212-21.
14. Landau S, Besinque K, Chung F, et al. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. J Am Pharm Assoc (2003) 2009;49:43-50.
15. American Public Health Association. The role of the pharmacist in public health. Available from http://www.apha.org/advocacy/policy/policysearch/default. htm?id=1338. Accessed November 11, 2009.
16. Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810-16.
17. Hatcher RA. Contraceptive technology, 19th ed. New York, NY: Ardent Media; 2007.
18. Department of Reproductive Health, World Health Organization. Medical eligibility criteria for contraceptive use, 3rd ed. Geneva, Switzerland: Reproductive Health and Research, World Health Organization; 2004.
19. Yeatman SE, Potter JE, Grossman DA. Over-the-counter access, changing WHO guidelines, and contraindicated oral contraceptive use in Mexico. Stud Fam Plann 2006;37:197-204. (Pubitemid 44363683)
20. Prata N, Vahidnia F, Potts M, Dries-Daffner I. Revisiting community-based distribution programs: are they still needed? Contraception 2005;72:402-7.
21. Shotorbani S, Miller L, Blough DK, Gardner J. Agreement between women's and providers' assessment of hormonal contraceptive risk factors. Contraception 2006;73:501-6.
22. Grossman D, Fernandez L, Hopkins K, Amastae J, Garcia SG, Potter JE. Accuracy of self-screening for contraindications to combined oral contraceptive use. Obstet Gynecol 2008;112:572-8.
23. Shortridge E, Miller K. Contraindications to oral contraceptive use among women in the United States, 1999-2001. Contraception 2007;75:355-60.
24. Kaskowitz AP, Carlson N, Nichols M, Edelman A, Jensen J. Online availability of hormonal contraceptives without a health care examination: effect of knowledge and health care screening. Contraception 2007;76:273-7.
25. Raine TR, Harper CC, Rocca CH, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA 2005;293:54-62. (Pubitemid 40066699)
26. Harper CC, Cheong M, Rocca CH, Darney PD, Raine TR. The effect of increased access to emergency contraception among young adolescents. Obstet Gynecol 2005;106:483-91. (Pubitemid 41208779)
27. Lo SS, Fan SY, Ho PC, Glasier AF. Effect of advanced provision of emergency contraception on women's contraceptive behaviour: a randomized controlled trial. Hum reprod 2004;19:2404-10. (Pubitemid 39406708)
28. Landau SC, Tapias MP, McGhee BT. Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 2006;74:463-70. (Pubitemid 46037536)
29. American College of Obstetricians and Gynecologists. Practice bulletin no. 109: cervical cytology screening. Obstet Gynecol 2009;114:1409-20.
30. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA 2001;285:2232-9. (Pubitemid 32416769)
31. Zavala AS, Perez-Gonzales M, Miller P, Welsh M, Wilkens LR, Potts M. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico. Stud Fam Plann 1987;18:284-90.
32. Shah MA, Shah NM, Al-Rahmani E, Behbehani J, Radovanovic Z. Over-the-counter use of oral contraceptives in Kuwait. Int J Gynaecol Obstet 2001;73:243-51. (Pubitemid 32455510)
33. Halpern V, Grimes DA, Lopez L, Gallo MF. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev 2006;(1):CD004317.
34. Moos MK, Bartholomew NE, Lohr KN. Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda. Contraception 2003;67:115-32. (Pubitemid 36174011)
35. Gee RE, Shacter HE, Kaufman EJ, Long JA. Behind-the-counter status and availability of emergency contraception. Am J Obstet Gynecol 2008;199:478.e1-5.
36. Dunn S, Brown TE, Alldred J. Availability of emergency contraception after its deregulation from prescription-only status: a survey of Ontario pharmacies. CMAJ 2008;178:423-4. (Pubitemid 351303284)
37. Moreau C, Bajos N, Trussell J. The impact of pharmacy access to emergency contraceptive pills in France. Contraception 2006;73:602-8. (Pubitemid 43786284)
38. Novikova N, Weisberg E, Fraser IS. Does readily available emergency contraception increase women's awareness and use? Eur J Contracept Reprod Health Care 2009;14:39-45.
39. Stone SC. Should oral contraceptives be sold over-the-counter? Am J Gynecol Health 1993;7:27-32.
40. National Institute for Reproductive Health, Low-Income Access Program. Expanding public health insurance coverage for EC. New York, NY: National Institute for Reproductive Health, 2010.
41. Harrington P, Shepherd MD. Analysis of the movement of prescription drugs to over-the-counter status. J Manag Care Pharm 2002;8:499-508.
42. West DS, Johnson JT, Hong SH. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan. J Manag Care Pharm 2006;12:25-32. (Pubitemid 47400553)
43. Foster DG, Rostovtseva DP, Brindis CD, Biggs MA, Hulett D, Darney PD. Cost savings from the provision of specific methods of contraception in a publicly funded program. Am J Public Health 2009;99:446-51.
44. Mead H. Making birth control more accessible to women: a cost-benefit analysis of over-the-counter oral contraceptives. Washington, DC: Institute for Women's Policy Research, 2001.
45. Dennis A, Blanchard K, Grossman D. Women's perceptions of advantages and disadvantages of moving oral contraceptives over the counter [abstract]. Presented at reproductive health 2009 the annual meeting of the Association for Reproductive Health Professionals and Society of Family Planning, Los Angeles, CA, September 30-October 3, 2009.
46. Grossman D, Fernandez L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas. Contraception 2010;81:254-60.
47. Monastersky Maderas NJ, Landau SC. Pharmacy and clinic partnerships to expand access to injectable contraception. J Am Pharm Assoc (2003) 2007;47:527-31.
48. Klein JD, Barratt MS, Blythe MJ, et al. Emergency contraception. Pediatrics 2005;116:1026-35. (Pubitemid 44542839)
49. American College of Obstetricians and Gynecologists. Statement of the American College of Obstetricians and Gynecologists on the FDA's approval of OTC status for Plan B, 2006. Available from http://www.acog.org/from-home/ publications/press-releases/nr08-24-06.cfm. Accessed August 31, 2009.
50. Oral Contraceptives Over-the-Counter Working Group. Statement of purpose. Available from http://www.rhtp.org/contraception/hormonal/documents/OCOTCGOALS- Jan08.pdf. Accessed March 23, 2010.
51. Association of Reproductive Health Professionals. National campaign to prevent teen and unplanned pregnancy. Provider's perspectives: perceived barriers to contraceptive use in youth and young adults. Washington, DC: Association of Reproductive Health Professionals, 2008.
52. National Conference of State Legislatures. Emergency contraception state laws. Available from http://www.ncsl.org/default.aspx?tabid=14420. Accessed March 23, 2010.
53. Denetclaw TH. The accuracy of pharmacists' HIV and condom counseling. Am J Public Health 1992;82:1420-1.
54. Frost JJ, Singh S, Finer LB. U.S. women's one-year contraceptive use patterns, 2004. Perspect Sex Reprod Health 2007;39:48-55.
55. Bunting BA, Smith BH, Sutherland SE. The Asheville project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) 2008;48:23-31.
56. Johnson JF, Koenigsfeld C, Hughell L, Parsa RA, Bravard S. Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies. J Am Pharm Assoc (2003) 2008;48:379-87.
57. March K, Mak M, Louie SG. Effects of pharmacists' interventions on patient outcomes in an HIV primary care clinic. Am J Health Syst Pharm 2007;64:2574-8. (Pubitemid 350276298)
58. Horberg MA, Hurley LB, Silverberg MJ, Kinsman CJ, Quesenberry CP. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Acquir Immune Defic Syndr 2007;44:531-9. (Pubitemid 46594896)
59. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. I. Systematic review and meta-analysis in diabetes management. Ann Pharmacother 2007;41:1569-82.
60. Knox ED, Dopheide JA, Wincor MZ, Han PK. Depression screening in a university campus pharmacy: a pilot project. J Am Pharm Assoc (2003) 2006;46:502-6. (Pubitemid 46037354)
61. Ahrens RA, Hower M, Best AM. Effects of weight reduction interventions by community pharmacists. J Am Pharm Assoc (2003) 2003;43:583-9.
62. MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 2005;25:379-86. (Pubitemid 40300325)
63. Accreditation Council for Pharmacy Education. Accreditation standards and guidelines for the professional program in pharmacy leading to the doctor of pharmacy degree. Chicago, IL: Accreditation Council for Pharmacy Education, 2006.
64. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control - continued disparities in adults: United States, 2005-2006. Hyattsville, MD: National Center for Health Statistics, 2008.
65. Hammel MI, Kabat HF. A case study: blood pressure screening in the community pharmacy. J Am Pharm Assoc 1974;14:196-7.
66. Fogel SB, Reid DA. Expanding access to over-the-counter family planning drugs and supplies. Washington, DC: National Health Law Program, 2009.
67. Patient Protection and Affordable Care Act. HR rep no. 3590; pub L no. 111-148 (March 23, 2010).
68. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists - 2003. Pharmacotherapy 2003;23:1210-25. (Pubitemid 37158791)